Literature DB >> 23983439

Clonality analysis of neuroendocrine cells in gastric adenocarcinoma.

Ling-Ling Wang1, Gen-You Yao, Zhong-Sheng Zhao, Xiao-Li Wei, Ru-Jun Xu.   

Abstract

AIM: To achieve a better understanding of the origination of neuroendocrine (NE) cells in gastric adenocarcinoma.
METHODS: In this study, 120 cases of gastric adenocarcinoma were obtained. First, frozen section-immunohistochemistrical samples were selected from a large quantity of neuroendocrine cells. Second, laser capture microdissection was used to get target cells from gastric adenocarcinoma and whole genome amplification was applied to get a large quantity of DNA for further study. Third, genome-wide microsatellite abnormalities [microsatellite instability (MSI), loss of heterozygosity (LOH)] and p53 mutation were detected by polymerase chain reaction (PCR)-single-strand conformation polymer- phism-silver staining and PCR-sequencing in order to identify the clonality of NE cells.
RESULTS: The total incidence rate of MSI was 27.4%, while LOH was 17.9%. Ten cases had a highest concordance for the two types of cells. The other samples had similar microsatellite changes, except for cases 7 and 10. Concordant p53 mutations exhibited in sample 4, 14, 21 and 27, and there were different mutations between two kinds of cells in case 7. In case 17, mutation took place only in adenocarcinoma cells. p53 mutation was closely related with degree of differentiation, tumor-node-metastasis stage, vessel invasion and lymph node metastasis. In brief, NE and adenocarcinoma cells showed the same MSI, LOH or p53 mutation in most cases (27/30). In the other three cases, different MSI, LOH or p53 mutation occurred.
CONCLUSION: NE and the gastric adenocarcinoma cells may mainly derive from the same stem cells, but the remaining cases showing different origin needs further investigation.

Entities:  

Keywords:  Clonal analysis; Gastric adenocarcinoma; Neuroendocrine cells; Neuroendocrine differentiation

Mesh:

Substances:

Year:  2013        PMID: 23983439      PMCID: PMC3752570          DOI: 10.3748/wjg.v19.i32.5340

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

1.  Neuroendocrine markers in adenocarcinomas: an investigation of 356 cases.

Authors:  Gen-You Yao; Ji-Lin Zhou; Mao-De Lai; Xiao-Qing Chen; Pei-Hui Chen
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

Review 2.  The p53 tumor suppressor gene: from molecular biology to clinical investigation.

Authors:  T Soussi
Journal:  Ann N Y Acad Sci       Date:  2000-06       Impact factor: 5.691

3.  Clonality of combined tumors.

Authors:  Jiaoti Huang; Carmen Behrens; Ignacio I Wistuba; Adi F Gazdar; Jaishree Jagirdar
Journal:  Arch Pathol Lab Med       Date:  2002-04       Impact factor: 5.534

4.  Genetic evidence for the multi-step progression of mixed glandular-neuroendocrine gastric carcinomas.

Authors:  Kyoung-Mee Kim; Min-Joo Kim; Bo-Kyoung Cho; Sang-Wook Choi; Mun-Gan Rhyu
Journal:  Virchows Arch       Date:  2002-01       Impact factor: 4.064

5.  Neuroendocrine differentiation in hormone refractory prostate cancer following androgen deprivation therapy.

Authors:  Daisaku Hirano; Yasuhiro Okada; Sadatsugu Minei; Yukie Takimoto; Norimichi Nemoto
Journal:  Eur Urol       Date:  2004-05       Impact factor: 20.096

Review 6.  Cellular and molecular biology of the prostate: stem cell biology.

Authors:  Jack A Schalken; Geert van Leenders
Journal:  Urology       Date:  2003-11       Impact factor: 2.649

7.  Carcinogenesis of gastric endocrine cell carcinoma: analysis of histopathology and p53 gene alteration.

Authors:  Ken Nishikura; Hidenobu Watanabe; Mitsuya Iwafuchi; Takato Fujiwara; Kazuko Kojima; Yoichi Ajioka
Journal:  Gastric Cancer       Date:  2003       Impact factor: 7.370

8.  Neuroendocrine differentiation in gastric adenocarcinomas; correlation with tumor stage and expression of VEGF and p53.

Authors:  Funda Eren; Ciğdem Celikel; Bahadir Güllüoğlu
Journal:  Pathol Oncol Res       Date:  2004-03-18       Impact factor: 3.201

9.  Evidence of tumor microsatellite instability in gastric cancer with familial aggregation.

Authors:  Corrado Pedrazzani; Giovanni Corso; Sérgia Velho; Marina Leite; Valeria Pascale; Francesca Bettarini; Daniele Marrelli; Raquel Seruca; Franco Roviello
Journal:  Fam Cancer       Date:  2009-01-17       Impact factor: 2.375

10.  Neuroendocrine differentiation in colorectal carcinomas: assessing its prognostic significance.

Authors:  Pinar Atasoy; Arzu Ensari; Salim Demirci; Nazmiye Kurşun
Journal:  Tumori       Date:  2003 Jan-Feb
View more
  4 in total

1.  Detection of microsatellite instability in gastric cancer and dysplasia tissues.

Authors:  Bing Li; Hong-Yi Liu; Shao-Hua Guo; Peng Sun; Fang-Ming Gong; Bao-Qing Jia
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  miR-135a inhibits tumor metastasis and angiogenesis by targeting FAK pathway.

Authors:  Zhenguo Cheng; Funan Liu; Hongyan Zhang; Xiaodong Li; Yanshu Li; Jiabin Li; Furong Liu; Yu Cao; Liu Cao; Feng Li
Journal:  Oncotarget       Date:  2017-05-09

3.  Prognostic Threshold of Neuroendocrine Differentiation in Gastric Carcinoma: a Clinicopathological Study of 945 Cases.

Authors:  Yi Zou; Linying Chen; Xingfu Wang; Yupeng Chen; Liwen Hu; Saifan Zeng; Pengcheng Wang; Guoping Li; Ming Huang; Liting Wang; Shi He; Sanyan Li; Lihui Jian; Sheng Zhang
Journal:  J Gastric Cancer       Date:  2019-03-20       Impact factor: 3.720

4.  A Previously Undescribed Presentation of Mixed Adenoneuroendocrine Carcinoma.

Authors:  Javier De Luca-Johnson; Maryam Zenali
Journal:  Case Rep Pathol       Date:  2016-11-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.